Cambridge Investment Research Advisors
ACA icon

Cambridge Investment Research Advisors’s Arcosa ACA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ACA Stock Details ACA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$416K Sell
2,862
-187
-6% -$23.2K ﹤0.01% 3138
2026
Q1 		$324K Buy
3,049
+53
+2% +$6.03K ﹤0.01% 3217
2025
Q4 		$318K Sell
2,996
-58
-2% -$5.86K ﹤0.01% 3144
2025
Q3 		$286K Buy
3,054
+217
+8% +$20.2K ﹤0.01% 3148
2025
Q2 		$246K Buy
+2,837
New +$237K ﹤0.01% 3150
2025
Q1 		– Sell
-2,159
Closed -$209K – 3497
2024
Q4 		$209K Sell
2,159
-24
-1% -$2.41K ﹤0.01% 3168
2024
Q3 		$207K Buy
+2,183
New +$191K ﹤0.01% 3124
2019
Q4 		– Sell
-13,788
Closed -$472K – 2405
2019
Q3 		$472K Buy
+13,788
New +$477K ﹤0.01% 1538

Other funds holding ACA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Cambridge Investment Research Advisors's ACA Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Arcosa (ACA) stake by 6.1% in Q2 2026, selling an estimated $23.2K and leaving 2,862 shares worth $416K. The position accounts for ﹤0.01% of the portfolio, ranked #3138.

Cambridge Investment Research Advisors first reported a position in ACA in Q3 2019 and has held it in 8 quarters since. The position peaked at $472K in Q3 2019. 425 funds tracked by Wall St. Rank hold ACA as of Q2 2026.

  • Cambridge Investment Research Advisors held 2,862 shares of Arcosa worth $416K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 187 Arcosa shares in Q2 2026, an estimated $23.2K.
  • Arcosa made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3138 holding.
  • Cambridge Investment Research Advisors first reported a position in Arcosa in Q3 2019 and has held it in 8 quarters since.
  • Cambridge Investment Research Advisors's Arcosa position peaked at $472K in Q3 2019.
  • 425 funds tracked by Wall St. Rank held Arcosa as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.